PATENT CLAIM ANALYSIS

Application Number: 16408602
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["530", "391900"]

Abstract:
Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.

Claim (Index 5):
A compound: wherein n is 4, and A is adalimumab.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 100.0
- Lexical Diversity: 1.21739
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15301564', '14772731', '15676726', '13883713', '14817455']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.651633363598707
- 35 USC 102 Novelty (BERT): 0.5414225171021791
- Combined Prediction Score: 0.6406122789490543
- Mean Citation Score: 211.869348
- Max Citation Score: 276.72116
- Similarity Product: 165.51344269416808

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test